Document_And_Entity_Informatio
Document And Entity Information | 9 Months Ended | |
Sep. 30, 2014 | Oct. 17, 2014 | |
Document and Entity Information [Abstract] | ' | ' |
Entity Registrant Name | 'ALPHA PRO TECH LTD | ' |
Document Type | '10-Q | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Common Stock, Shares Outstanding | ' | 18,298,009 |
Amendment Flag | 'false | ' |
Entity Central Index Key | '0000884269 | ' |
Entity Current Reporting Status | 'Yes | ' |
Entity Voluntary Filers | 'No | ' |
Entity Filer Category | 'Smaller Reporting Company | ' |
Entity Well-known Seasoned Issuer | 'No | ' |
Document Period End Date | 30-Sep-14 | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Condensed_Consolidated_Balance
Condensed Consolidated Balance Sheets (Unaudited) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | |
Current assets: | ' | ' | |
Cash and cash equivalents | $7,053,000 | $8,215,000 | [1] |
Investments | 2,426,000 | 1,606,000 | [1] |
Accounts receivable, net of allowance for doubtful accounts of $82,000 and $85,000 as of September 30, 2014 and December 31, 2013, respectively | 6,148,000 | 5,071,000 | [1] |
Inventories | 13,671,000 | 14,140,000 | [1] |
Prepaid expenses | 4,115,000 | 2,968,000 | [1] |
Deferred income tax assets | 577,000 | 640,000 | [1] |
Total current assets | 33,990,000 | 32,640,000 | [1] |
Property and equipment, net | 3,415,000 | 3,068,000 | [1] |
Goodwill | 55,000 | 55,000 | [1] |
Definite-lived intangible assets, net | 75,000 | 92,000 | [1] |
Equity investment in unconsolidated affiliate | 2,924,000 | 2,708,000 | [1] |
Total assets | 40,459,000 | 38,563,000 | [1] |
Current liabilities: | ' | ' | |
Accounts payable | 1,250,000 | 689,000 | [1] |
Accrued liabilities | 915,000 | 1,036,000 | [1] |
Total current liabilities | 2,165,000 | 1,725,000 | [1] |
Deferred income tax liabilities | 1,624,000 | 1,257,000 | [1] |
Total liabilities | 3,789,000 | 2,982,000 | [1] |
Shareholders' equity: | ' | ' | |
Common stock, $.01 par value: 50,000,000 shares authorized; 18,213,009 and 18,878,109 shares outstanding as of September 30, 2014 and December 31, 2013, respectively | 182,000 | 189,000 | [1] |
Additional paid-in capital | 17,477,000 | 18,994,000 | [1] |
Accumulated other comprehensive income | 1,108,000 | 625,000 | [1] |
Retained earnings | 17,903,000 | 15,773,000 | [1] |
Total shareholders' equity | 36,670,000 | 35,581,000 | [1] |
Total liabilities and shareholders' equity | $40,459,000 | $38,563,000 | [1] |
[1] | The condensed consolidated balance sheet as of December 31, 2013 has been prepared using information from the audited consolidated balance sheet as of that date. |
Condensed_Consolidated_Balance1
Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | |
Allowance for doubtful accounts (in Dollars) | $82,000 | $85,000 | [1] |
Common stock, par value (in Dollars per share) | $0.01 | $0.01 | [1] |
Common stock, shares authorized | 50,000,000 | 50,000,000 | [1] |
Common stock, shares outstanding | 18,213,009 | 18,878,109 | |
[1] | The condensed consolidated balance sheet as of December 31, 2013 has been prepared using information from the audited consolidated balance sheet as of that date. |
Condensed_Consolidated_Stateme
Condensed Consolidated Statements of Income (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |
Net sales | $13,213,000 | $12,692,000 | $35,421,000 | $33,298,000 |
Cost of goods sold, excluding depreciation and amortization | 8,327,000 | 8,113,000 | 22,416,000 | 20,999,000 |
Gross profit | 4,886,000 | 4,579,000 | 13,005,000 | 12,299,000 |
Selling, general and administrative | 3,288,000 | 3,190,000 | 9,958,000 | 9,885,000 |
Depreciation and amortization | 198,000 | 178,000 | 562,000 | 534,000 |
Total operating expenses | 3,486,000 | 3,368,000 | 10,520,000 | 10,419,000 |
Income from operations | 1,400,000 | 1,211,000 | 2,485,000 | 1,880,000 |
Other income: | ' | ' | ' | ' |
Equity in income of unconsolidated affiliate | 22,000 | 101,000 | 216,000 | 172,000 |
Gain on investments in common stock and common stock warrants | ' | ' | 409,000 | ' |
Interest income | 4,000 | 1,000 | 13,000 | 3,000 |
Total other income | 26,000 | 102,000 | 638,000 | 175,000 |
Income before provision for income taxes | 1,426,000 | 1,313,000 | 3,123,000 | 2,055,000 |
Provision for income taxes | 460,000 | 408,000 | 993,000 | 660,000 |
Net income | $966,000 | $905,000 | $2,130,000 | $1,395,000 |
Basic earnings per common share (in Dollars per share) | $0.05 | $0.05 | $0.12 | $0.07 |
Diluted earnings per common share (in Dollars per share) | $0.05 | $0.05 | $0.11 | $0.07 |
Basic weighted average common shares outstanding (in Shares) | 18,107,073 | 19,008,660 | 18,429,985 | 19,326,491 |
Diluted weighted average common shares outstanding (in Shares) | 18,387,422 | 19,009,656 | 18,689,274 | 19,326,491 |
Condensed_Consolidated_Stateme1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |
Net income | $966,000 | $905,000 | $2,130,000 | $1,395,000 |
Other comprehensive income: | ' | ' | ' | ' |
Change in unrealized gain (loss) on marketable securities, net of tax | -278,000 | 289,000 | 728,000 | 358,000 |
Reclassification adjustment for gains included in net income | ' | ' | -245,000 | ' |
Total other comprehensive income (loss) | -278,000 | 289,000 | 483,000 | 358,000 |
Comprehensive income | $688,000 | $1,194,000 | $2,613,000 | $1,753,000 |
Condensed_Consolidated_Stateme2
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) (USD $) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Accumulated Other Comprehensive Income (Loss) [Member] | Total | |
Balance at Dec. 31, 2013 | $189,000 | $18,994,000 | $15,773,000 | $625,000 | $35,581,000 | [1] |
Balance (in Shares) at Dec. 31, 2013 | 18,878,109 | ' | ' | ' | 18,878,109 | |
Options exercised | 3,000 | 447,000 | ' | ' | 450,000 | |
Options exercised (in Shares) | 285,000 | ' | ' | ' | -285,000 | |
Stock-based compensation expense | ' | 25,000 | ' | ' | 25,000 | |
Common stock repurchased and retired | -10,000 | -2,024,000 | ' | ' | -2,034,000 | |
Common stock repurchased and retired (in Shares) | -950,100 | ' | ' | ' | ' | |
Excess tax benefit from stock options exercised | ' | 35,000 | ' | ' | 35,000 | |
Net income | ' | ' | 2,130,000 | ' | 2,130,000 | |
Other comprehensive income | ' | ' | ' | 483,000 | 483,000 | |
Balance at Sep. 30, 2014 | $182,000 | $17,477,000 | $17,903,000 | $1,108,000 | $36,670,000 | |
Balance (in Shares) at Sep. 30, 2014 | 18,213,009 | ' | ' | ' | 18,213,009 | |
[1] | The condensed consolidated balance sheet as of December 31, 2013 has been prepared using information from the audited consolidated balance sheet as of that date. |
Condensed_Consolidated_Stateme3
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | ||
Cash Flows From Operating Activities: | ' | ' | |
Net income | $2,130,000 | $1,395,000 | |
Adjustments to reconcile net income to net cash provided by operating activities: | ' | ' | |
Stock-based compensation expense | 25,000 | 141,000 | |
Depreciation and amortization | 562,000 | 534,000 | |
Equity in income of unconsolidated affiliate | -216,000 | -172,000 | |
Gain on investment in common stock warrants | -30,000 | ' | |
Gain on sale of marketable securities | -379,000 | ' | |
Deferred income taxes | 196,000 | -14,000 | |
Changes in assets and liabilities: | ' | ' | |
Accounts receivable, net | -1,077,000 | 415,000 | |
Inventories | 469,000 | 3,523,000 | |
Prepaid expenses | -1,147,000 | -50,000 | |
Accounts payable and accrued liabilities | 440,000 | -423,000 | |
Net cash provided by operating activities | 973,000 | 5,349,000 | |
Cash Flows From Investing Activities: | ' | ' | |
Purchase of property and equipment | -892,000 | -284,000 | |
Purchase of intangible assets | ' | -1,000 | |
Purchase of marketable securities | -134,000 | ' | |
Proceeds from sale of marketable securities | 440,000 | ' | |
Net cash used in investing activities | -586,000 | -285,000 | |
Cash Flows From Financing Activities: | ' | ' | |
Proceeds from exercise of stock options | 450,000 | 514,000 | |
Repurchase of common stock | -2,034,000 | -2,422,000 | |
Excess tax benefit (expense) on stock options exercised | 35,000 | -1,000 | |
Net cash used in financing activities | -1,549,000 | -1,909,000 | |
Net (decrease) increase in cash and cash equivalents | -1,162,000 | 3,155,000 | |
Cash and cash equivalents, beginning of the period | 8,215,000 | [1] | 4,554,000 |
Cash and cash equivalents, end of the period | $7,053,000 | $7,709,000 | |
[1] | The condensed consolidated balance sheet as of December 31, 2013 has been prepared using information from the audited consolidated balance sheet as of that date. |
Note_1_The_Company
Note 1 - The Company | 9 Months Ended | |
Sep. 30, 2014 | ||
Disclosure Text Block [Abstract] | ' | |
Nature of Operations [Text Block] | ' | |
1 | The Company | |
Alpha Pro Tech, Ltd. (“Alpha Pro Tech” or the “Company”) is in the business of protecting people, products and environments. The Company accomplishes this by developing, manufacturing and marketing a line of building supply products for the new home and re-roofing markets; a line of disposable protective apparel for the cleanroom, industrial and pharmaceutical markets; and a line of infection control products for the medical and dental markets. | ||
The Building Supply segment consists of construction weatherization products, such as housewrap and synthetic roof underlayment, as well as other woven material. | ||
The Disposable Protective Apparel segment consists of a complete line of shoecovers, bouffant caps, coveralls, gowns, frocks and lab coats. | ||
The Infection Control segment consists of a line of face masks and eye shields. | ||
The Company’s products are sold under the "Alpha Pro Tech" brand name, and under private label, and are predominantly sold in the United States of America (“US”). |
Note_2_Basis_of_Presentation
Note 2 - Basis of Presentation | 9 Months Ended | |
Sep. 30, 2014 | ||
Disclosure Text Block [Abstract] | ' | |
Basis of Presentation and Significant Accounting Policies [Text Block] | ' | |
2 | Basis of Presentation | |
The interim financial information included herein is unaudited; however, the information reflects all adjustments (consisting of normal recurring adjustments) that are, in the opinion of management, necessary for the fair presentation of the consolidated financial position, results of operations and cash flows for the interim periods. These interim condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, omit certain information and note disclosures necessary to present the statements in accordance with US generally accepted accounting principles (“US GAAP”). The interim condensed consolidated financial statements should be read in conjunction with the Company’s current year SEC filings on Form 10-Q and Form 8-K, as well as the consolidated financial statements for the year ended December 31, 2013, which are included in the Company’s Annual Report on Form 10-K (the “2013 Form 10-K”), which was filed on March 6, 2014. The results of operations for the three and nine months ended September 30, 2014 reported in this Form 10-Q are not necessarily indicative of the results to be expected for the full year. The condensed consolidated balance sheet as of December 31, 2013 was prepared using information from the audited consolidated balance sheet contained in the 2013 Form 10-K, and does not include all disclosures required by US GAAP for annual consolidated financial statements. |
Note_3_StockBased_Compensation
Note 3 - Stock-Based Compensation | 9 Months Ended | ||||||||||||
Sep. 30, 2014 | |||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | ||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | ' | ||||||||||||
3 | Stock-Based Compensation | ||||||||||||
The Company maintains a stock option plan under which the Company may grant incentive stock options and non-qualified stock options to employees and non-employee directors. Stock options have been granted with exercise prices at or above the fair market value of the underlying shares of common stock on the date of grant. Options vest and expire according to terms established at the grant date. | |||||||||||||
The Company records compensation expense for the fair value of stock-based awards determined as of the grant date, including employee stock options. | |||||||||||||
For the three and nine months ended September 30, 2014 and 2013, there were no stock options granted under the Company’s option plan. The Company recognized $25,000 and $141,000 in stock-based compensation expense for the nine months ended September 30, 2014 and 2013, respectively, related to the vesting of previously issued options. | |||||||||||||
Stock options to purchase 785,000 and 1,415,000 shares of common stock were outstanding as of September 30, 2014 and 2013, respectively. | |||||||||||||
The Company uses the Black-Scholes option-pricing model to value the options. The Company uses historical data to estimate the life of the options. The risk-free interest rate for periods within the contractual life of the award is based on the US Treasury yield curve in effect at the time of grant. The estimated volatility is based on historical volatility and management’s expectations of future volatility. The Company uses an estimated dividend payout of zero, as the Company has not paid dividends in the past and, at this time, does not expect to do so in the future. | |||||||||||||
The following table summarizes stock option activity for the nine months ended September 30, 2014: | |||||||||||||
Options | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life (in years) | |||||||||||
Options outstanding as of December 31, 2013 | 1,070,000 | $ | 1.58 | 1.97 | |||||||||
Granted | - | - | - | ||||||||||
Exercised | (285,000 | ) | 1.58 | - | |||||||||
Canceled/expired/forfeited | - | - | - | ||||||||||
Options outstanding as of September 30, 2014 | 785,000 | 1.58 | 1.41 | ||||||||||
Options exercisable as of September 30, 2014 | 770,000 | 1.59 | 1.01 | ||||||||||
As of September 30, 2014, $47,000 of total unrecognized compensation cost related to stock options was expected to be recognized over a weighted average period of 1.9 years. |
Note_4_Investments
Note 4 - Investments | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Investments, Debt and Equity Securities [Abstract] | ' | ||||||||
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] | ' | ||||||||
4 | Investments | ||||||||
As of December 31, 2013, investments totaled $1,606,000, which consisted of available-for-sale marketable securities of $1,256,000 and non-trading common stock warrants of $350,000. As of September 30, 2014, investments totaled $2,426,000, all of which were available-for-sale marketable securities. | |||||||||
The following provides information regarding the Company’s marketable securities as of September 30, 2014 and December 31, 2013: | |||||||||
September 30, | December 31, | ||||||||
2014 | 2013 | ||||||||
Cost basis | $ | 328,000 | $ | 255,000 | |||||
Unrealized gains included in accumulated other comprehensive income | 1,718,000 | 1,001,000 | |||||||
Realized gains previously recognized as warrants | 380,000 | - | |||||||
Fair value | $ | 2,426,000 | $ | 1,256,000 | |||||
Certain marketable securities were sold during the nine months ended September 30, 2014. No marketable securities were sold during the year ended December 31, 2013. Realized gains recognized from the sale of marketable securities during the nine months ended September 30, 2014 were $379,000 ($245,000 net of tax, which is the amount reclassified out of accumulated other comprehensive income). For the nine months ended September 30, 2014 and 2013, unrealized gains on marketable securities of $717,000 and $574,000, respectively, are presented net of taxes of $234,000 and $216,000, resulting in after tax gains of $483,000 and $358,000. For the three months ended September 30, 2014 and 2013, unrealized losses of $430,000 and unrealized gains of $463,000 on marketable securities, respectively, are presented net of taxes of ($152,000) and $174,000, resulting in an after tax loss of $278,000 and an after tax gain of $289,000. | |||||||||
Prior to the first quarter of 2014, the Company held warrants to purchase up to 167,500 shares of common stock of an entity which were set to expire in September 2014. The Company exercised all of the warrants in the first quarter of 2014. Prior to the exercise, the Company recognized a $30,000 gain during the first quarter of 2014 based upon the appreciation in the fair value of the underlying common stock. |
Note_5_New_Accounting_Standard
Note 5 - New Accounting Standard | 9 Months Ended | |
Sep. 30, 2014 | ||
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | ' | |
New Accounting Pronouncements and Changes in Accounting Principles [Text Block] | ' | |
5 | New Accounting Standard | |
Recent Accounting Pronouncement – In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to a customer at an amount reflecting the consideration it expects to receive in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. ASU 2014-09 is effective for the first interim period within an annual reporting period beginning after December 15, 2016, and early adoption is not permitted. The Company will adopt ASU 2014-09 during the first quarter of fiscal 2017. Management is evaluating the provisions of this update and has not determined the impact its adoption will have on the Company’s financial position or results of operations. | ||
Management periodically reviews new accounting standards that are issued. Management has not identified any other new standards that it believes merit further discussion. |
Note_6_Inventories
Note 6 - Inventories | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Inventory Disclosure [Abstract] | ' | ||||||||
Inventory Disclosure [Text Block] | ' | ||||||||
6 | Inventories | ||||||||
As of September 30, 2014 and December 31, 2013, inventories consisted of the following: | |||||||||
September 30, | December 31, | ||||||||
2014 | 2013 | ||||||||
Raw materials | $ | 5,546,000 | $ | 5,876,000 | |||||
Work in process | 3,811,000 | 2,178,000 | |||||||
Finished goods | 4,314,000 | 6,086,000 | |||||||
$ | 13,671,000 | $ | 14,140,000 | ||||||
Note_7_Equity_Investments_in_U
Note 7 - Equity Investments in Unconsolidated Affiliate | 9 Months Ended | |
Sep. 30, 2014 | ||
Equity Method Investments and Joint Ventures [Abstract] | ' | |
Equity Method Investments and Joint Ventures Disclosure [Text Block] | ' | |
7 | Equity Investment in Unconsolidated Affiliate | |
In 2005, Alpha ProTech Engineered Products, Inc. (a subsidiary of Alpha Pro Tech, Ltd.) entered into a joint venture with a manufacturer in India for the production of building products. Under the terms of the joint venture agreement, a private company, Harmony Plastics Private Limited (“Harmony”), was created with ownership interests of 41.66% by Alpha ProTech Engineered Products, Inc. and 58.34% by Maple Industries and Associates. Alpha ProTech Engineered Products, Inc. contributed $508,000 for its equity position, and Maple Industries and Associates contributed $708,000 for its equity position. | ||
This joint venture positions Alpha ProTech Engineered Products, Inc. to respond to current and expected increased product demand for housewrap and synthetic roof underlayment and provides future capacity for sales of specialty roofing component products and custom products for industrial applications requiring high quality extrusion coated fabrics. In addition, the joint venture supplies products for the Disposable Protective Apparel segment. | ||
The capital from the initial funding and a bank loan, which loan is guaranteed exclusively by the individual shareholders of Maple Industries and Associates and collateralized by the assets of Harmony, were utilized to purchase the original manufacturing facility in India. Harmony currently has four facilities in India (three owned and one rented), consisting of: (1) a 102,000 square foot building for manufacturing housewrap and synthetic roof underlayment; (2) a 71,500 square foot building for manufacturing coated material and sewing proprietary disposable protective apparel; (3) a 16,000 square foot facility for sewing proprietary disposable protective apparel; and (4) a 12,000 square foot rented facility for coating material. All additions have been financed by Harmony with no guarantees from the Company. | ||
The Company assesses whether or not related entities are variable interest entities (“VIEs”). For those related entities that qualify as VIEs, the Company determines whether or not it is the primary beneficiary of the VIE, and, if so, the Company will consolidate the VIE. The Company has determined that Harmony is not a VIE and is, therefore, considered to be an unconsolidated affiliate. | ||
The Company records its investment in Harmony as “equity investment in unconsolidated affiliate” in the accompanying balance sheets. The Company records its equity interest in Harmony’s results of operations as “equity in income of unconsolidated affiliate” in the accompanying statements of income. The Company reviews annually its investment in Harmony for impairment. Management has determined that no impairment was required as of September 30, 2014. | ||
For the three months ended September 30, 2014 and 2013, Alpha Pro Tech purchased $5,019,000 and $4,140,000 of inventories, respectively, from Harmony. For the nine months ended September 30, 2014 and 2013, Alpha Pro Tech purchased $13,486,000 and $9,132,000 of inventories, respectively, from Harmony. | ||
For the three months ended September 30, 2014 and 2013, the Company recorded equity in income of unconsolidated affiliate of $22,000 and $101,000, respectively. For the nine months ended September 30, 2014 and 2013, the Company recorded equity in income of unconsolidated affiliate of $216,000 and $172,000, respectively. | ||
As of September 30, 2014, the Company’s investment in Harmony was $2,924,000, which consisted of its original $1,450,000 investment and cumulative equity in income of unconsolidated affiliate of $2,494,000, less $942,000 in repayments of the advance and payment of $77,000 in dividends. |
Note_8_Accrued_Liabilities
Note 8 - Accrued Liabilities | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Payables and Accruals [Abstract] | ' | ||||||||
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | ' | ||||||||
8 | Accrued Liabilities | ||||||||
As of September 30, 2014 and December 31, 2013, accrued liabilities consisted of the following: | |||||||||
September 30, | December 31, | ||||||||
2014 | 2013 | ||||||||
Payroll expenses | $ | 248,000 | $ | 178,000 | |||||
Bonuses payable | 473,000 | 664,000 | |||||||
Uncertain tax position | 194,000 | 194,000 | |||||||
$ | 915,000 | $ | 1,036,000 | ||||||
Note_9_Basic_and_Diluted_Earni
Note 9 - Basic and Diluted Earnings Per Common Share | 9 Months Ended | ||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||
Earnings Per Share [Abstract] | ' | ||||||||||||||||
Earnings Per Share [Text Block] | ' | ||||||||||||||||
9 | Basic and Diluted Earnings Per Common Share | ||||||||||||||||
The following table provides a reconciliation of both net income and the number of shares used in the computation of “basic” earnings per common share (“EPS”), which utilizes the weighted average number of common shares outstanding without regard to potential shares, and “diluted” EPS, which includes all such dilutive shares, for the three and nine months ended September 30, 2014 and 2013. | |||||||||||||||||
For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Net income (numerator) | $ | 966,000 | $ | 905,000 | $ | 2,130,000 | $ | 1,395,000 | |||||||||
Shares (denominator): | |||||||||||||||||
Basic weighted average common shares outstanding | 18,107,073 | 19,008,660 | 18,429,985 | 19,326,491 | |||||||||||||
Add: Dilutive effect of common stock options | 280,349 | 996 | 259,289 | - | |||||||||||||
Diluted weighted average common shares outstanding | 18,387,422 | 19,009,656 | 18,689,274 | 19,326,491 | |||||||||||||
Earnings per common share: | |||||||||||||||||
Basic | $ | 0.05 | $ | 0.05 | $ | 0.12 | $ | 0.07 | |||||||||
Diluted | $ | 0.05 | $ | 0.05 | $ | 0.11 | $ | 0.07 | |||||||||
Note_10_Activity_of_Business_S
Note 10 - Activity of Business Segments | 9 Months Ended | ||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||
Segment Reporting Disclosure [Text Block] | ' | ||||||||||||||||
10 | Activity of Business Segments | ||||||||||||||||
The Company operates through three business segments: | |||||||||||||||||
Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment, as well as other woven material. The Company’s equity in income of unconsolidated affiliate (Harmony) is included in the total segment income for the Building Supply segment. | |||||||||||||||||
Disposable Protective Apparel: consisting of a complete line of disposable protective clothing, such as shoecovers (including the Aqua Trak® and spunbond shoecovers), bouffant caps, coveralls, frocks, lab coats, gowns and hoods for the pharmaceutical, cleanroom, industrial and medical markets. | |||||||||||||||||
Infection Control: consisting of a line of face masks and eye shields. | |||||||||||||||||
Segment data excludes charges allocated to the principal executive office, corporate expenses and income taxes. The Company evaluates the performance of its segments and allocates resources to them based primarily on net sales. | |||||||||||||||||
The following table presents consolidated net sales for each segment for the three and nine months ended September 30, 2014 and 2013: | |||||||||||||||||
For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Building Supply | $ | 8,546,000 | $ | 8,238,000 | $ | 21,482,000 | $ | 20,460,000 | |||||||||
Disposable Protective Apparel | 3,456,000 | 3,336,000 | 10,612,000 | 9,610,000 | |||||||||||||
Infection Control | 1,211,000 | 1,118,000 | 3,327,000 | 3,228,000 | |||||||||||||
Total net sales | $ | 13,213,000 | $ | 12,692,000 | $ | 35,421,000 | $ | 33,298,000 | |||||||||
The following table presents the reconciliation of consolidated segment income to consolidated net income for the three and nine months ended September 30, 2014 and 2013: | |||||||||||||||||
For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Building Supply | $ | 1,749,000 | $ | 1,668,000 | $ | 3,893,000 | $ | 3,668,000 | |||||||||
Disposable Protective Apparel | 395,000 | 389,000 | 1,161,000 | 950,000 | |||||||||||||
Infection Control | 392,000 | 403,000 | 1,047,000 | 1,052,000 | |||||||||||||
Total Consolidated segment income | 2,536,000 | 2,460,000 | 6,101,000 | 5,670,000 | |||||||||||||
Gain on marketable securities | - | - | 409,000 | - | |||||||||||||
Unallocated corporate overhead expenses | 1,110,000 | 1,147,000 | 3,387,000 | 3,615,000 | |||||||||||||
Provision for income taxes | 460,000 | 408,000 | 993,000 | 660,000 | |||||||||||||
Consolidated net income | $ | 966,000 | $ | 905,000 | $ | 2,130,000 | $ | 1,395,000 | |||||||||
The following table presents the consolidated net property and equipment, goodwill and definite-lived intangible assets (“consolidated assets”) by segment as of September 30, 2014 and December 31, 2013: | |||||||||||||||||
September 30, | December 31, | ||||||||||||||||
2014 | 2013 | ||||||||||||||||
Building Supply | $ | 2,668,000 | $ | 2,144,000 | |||||||||||||
Disposable Protective Apparel | 449,000 | 483,000 | |||||||||||||||
Infection Control | 420,000 | 568,000 | |||||||||||||||
Consolidated segment assets | 3,537,000 | 3,195,000 | |||||||||||||||
Unallocated corporate assets | 8,000 | 20,000 | |||||||||||||||
Total Consolidated assets | $ | 3,545,000 | $ | 3,215,000 | |||||||||||||
Note_11_Subsequent_Events
Note 11 - Subsequent Events | 9 Months Ended | |
Sep. 30, 2014 | ||
Subsequent Events [Abstract] | ' | |
Subsequent Events [Text Block] | ' | |
11 | Subsequent Events | |
The Company has reviewed and evaluated whether subsequent events have occurred from the condensed consolidated balance sheet date of September 30, 2014 through the filing date of this Form 10-Q that would require accounting or disclosure and has concluded that there are none. |
Note_3_StockBased_Compensation1
Note 3 - Stock-Based Compensation (Tables) | 9 Months Ended | ||||||||||||
Sep. 30, 2014 | |||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | ||||||||||||
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | ' | ||||||||||||
Options | Weighted Average Exercise Price | Weighted Average Remaining Contractual Life (in years) | |||||||||||
Options outstanding as of December 31, 2013 | 1,070,000 | $ | 1.58 | 1.97 | |||||||||
Granted | - | - | - | ||||||||||
Exercised | (285,000 | ) | 1.58 | - | |||||||||
Canceled/expired/forfeited | - | - | - | ||||||||||
Options outstanding as of September 30, 2014 | 785,000 | 1.58 | 1.41 | ||||||||||
Options exercisable as of September 30, 2014 | 770,000 | 1.59 | 1.01 |
Note_4_Investments_Tables
Note 4 - Investments (Tables) | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Investments, Debt and Equity Securities [Abstract] | ' | ||||||||
Schedule of Available-for-sale Securities Reconciliation [Table Text Block] | ' | ||||||||
September 30, | December 31, | ||||||||
2014 | 2013 | ||||||||
Cost basis | $ | 328,000 | $ | 255,000 | |||||
Unrealized gains included in accumulated other comprehensive income | 1,718,000 | 1,001,000 | |||||||
Realized gains previously recognized as warrants | 380,000 | - | |||||||
Fair value | $ | 2,426,000 | $ | 1,256,000 |
Note_6_Inventories_Tables
Note 6 - Inventories (Tables) | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Inventory Disclosure [Abstract] | ' | ||||||||
Schedule of Inventory, Current [Table Text Block] | ' | ||||||||
September 30, | December 31, | ||||||||
2014 | 2013 | ||||||||
Raw materials | $ | 5,546,000 | $ | 5,876,000 | |||||
Work in process | 3,811,000 | 2,178,000 | |||||||
Finished goods | 4,314,000 | 6,086,000 | |||||||
$ | 13,671,000 | $ | 14,140,000 |
Note_8_Accrued_Liabilities_Tab
Note 8 - Accrued Liabilities (Tables) | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Payables and Accruals [Abstract] | ' | ||||||||
Schedule of Accrued Liabilities [Table Text Block] | ' | ||||||||
September 30, | December 31, | ||||||||
2014 | 2013 | ||||||||
Payroll expenses | $ | 248,000 | $ | 178,000 | |||||
Bonuses payable | 473,000 | 664,000 | |||||||
Uncertain tax position | 194,000 | 194,000 | |||||||
$ | 915,000 | $ | 1,036,000 |
Note_9_Basic_and_Diluted_Earni1
Note 9 - Basic and Diluted Earnings Per Common Share (Tables) | 9 Months Ended | ||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||
Earnings Per Share [Abstract] | ' | ||||||||||||||||
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | ' | ||||||||||||||||
For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Net income (numerator) | $ | 966,000 | $ | 905,000 | $ | 2,130,000 | $ | 1,395,000 | |||||||||
Shares (denominator): | |||||||||||||||||
Basic weighted average common shares outstanding | 18,107,073 | 19,008,660 | 18,429,985 | 19,326,491 | |||||||||||||
Add: Dilutive effect of common stock options | 280,349 | 996 | 259,289 | - | |||||||||||||
Diluted weighted average common shares outstanding | 18,387,422 | 19,009,656 | 18,689,274 | 19,326,491 | |||||||||||||
Earnings per common share: | |||||||||||||||||
Basic | $ | 0.05 | $ | 0.05 | $ | 0.12 | $ | 0.07 | |||||||||
Diluted | $ | 0.05 | $ | 0.05 | $ | 0.11 | $ | 0.07 |
Note_10_Activity_of_Business_S1
Note 10 - Activity of Business Segments (Tables) | 9 Months Ended | ||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||
Schedule of Segment Reporting Information, by Segment [Table Text Block] | ' | ||||||||||||||||
For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Building Supply | $ | 8,546,000 | $ | 8,238,000 | $ | 21,482,000 | $ | 20,460,000 | |||||||||
Disposable Protective Apparel | 3,456,000 | 3,336,000 | 10,612,000 | 9,610,000 | |||||||||||||
Infection Control | 1,211,000 | 1,118,000 | 3,327,000 | 3,228,000 | |||||||||||||
Total net sales | $ | 13,213,000 | $ | 12,692,000 | $ | 35,421,000 | $ | 33,298,000 | |||||||||
Reconciliation of Revenue from Segments to Consolidated [Table Text Block] | ' | ||||||||||||||||
For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Building Supply | $ | 1,749,000 | $ | 1,668,000 | $ | 3,893,000 | $ | 3,668,000 | |||||||||
Disposable Protective Apparel | 395,000 | 389,000 | 1,161,000 | 950,000 | |||||||||||||
Infection Control | 392,000 | 403,000 | 1,047,000 | 1,052,000 | |||||||||||||
Total Consolidated segment income | 2,536,000 | 2,460,000 | 6,101,000 | 5,670,000 | |||||||||||||
Gain on marketable securities | - | - | 409,000 | - | |||||||||||||
Unallocated corporate overhead expenses | 1,110,000 | 1,147,000 | 3,387,000 | 3,615,000 | |||||||||||||
Provision for income taxes | 460,000 | 408,000 | 993,000 | 660,000 | |||||||||||||
Consolidated net income | $ | 966,000 | $ | 905,000 | $ | 2,130,000 | $ | 1,395,000 | |||||||||
Reconciliation of Assets from Segment to Consolidated [Table Text Block] | ' | ||||||||||||||||
September 30, | December 31, | ||||||||||||||||
2014 | 2013 | ||||||||||||||||
Building Supply | $ | 2,668,000 | $ | 2,144,000 | |||||||||||||
Disposable Protective Apparel | 449,000 | 483,000 | |||||||||||||||
Infection Control | 420,000 | 568,000 | |||||||||||||||
Consolidated segment assets | 3,537,000 | 3,195,000 | |||||||||||||||
Unallocated corporate assets | 8,000 | 20,000 | |||||||||||||||
Total Consolidated assets | $ | 3,545,000 | $ | 3,215,000 |
Note_3_StockBased_Compensation2
Note 3 - Stock-Based Compensation (Details) (USD $) | 3 Months Ended | 6 Months Ended | 9 Months Ended | |||
Sep. 30, 2014 | Sep. 30, 2013 | Jun. 30, 2014 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 0 | 0 | ' | 0 | 0 | ' |
Allocated Share-based Compensation Expense (in Dollars) | ' | ' | ' | $25,000 | $141,000 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 785,000 | 1,415,000 | ' | 785,000 | 1,415,000 | 1,070,000 |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | ' | ' | 0.00% | ' | ' | ' |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars) | $47,000 | ' | ' | $47,000 | ' | ' |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | ' | ' | ' | '1 year 328 days | ' | ' |
Note_3_StockBased_Compensation3
Note 3 - Stock-Based Compensation (Details) - Stock Option Activity (USD $) | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | |
Stock Option Activity [Abstract] | ' | ' | ' |
Options | 785,000 | 1,070,000 | 1,415,000 |
Weighted Average Exercise Price | $1.58 | $1.58 | ' |
Weighted Average Remaining Contractual Life (in years) | '1 year 149 days | '1 year 354 days | ' |
Options exercisable as of September 30, 2014 | 770,000 | ' | ' |
Options exercisable as of September 30, 2014 | $1.59 | ' | ' |
Options exercisable as of September 30, 2014 | '1 year 3 days | ' | ' |
Exercised | -285,000 | ' | ' |
Exercised | $1.58 | ' | ' |
Note_4_Investments_Details
Note 4 - Investments (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||||
Sep. 30, 2014 | Mar. 31, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 | ||
Note 4 - Investments (Details) [Line Items] | ' | ' | ' | ' | ' | ' | |
Available-for-sale Securities, Current | $2,426,000 | ' | ' | $2,426,000 | ' | $1,606,000 | [1] |
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | ' | ' | ' | 245,000 | ' | ' | |
Marketable Securities, Unrealized Gain (Loss) | -430,000 | ' | 463,000 | 717,000 | 574,000 | ' | |
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax | 152,000 | ' | 174,000 | 234,000 | 216,000 | ' | |
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax | -278,000 | ' | 289,000 | 483,000 | 358,000 | ' | |
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | ' | ' | ' | ' | ' | 167,500 | |
Derivative, Gain on Derivative | ' | 30,000 | ' | ' | ' | ' | |
Marketable Securities [Member] | ' | ' | ' | ' | ' | ' | |
Note 4 - Investments (Details) [Line Items] | ' | ' | ' | ' | ' | ' | |
Available-for-sale Securities, Current | 2,426,000 | ' | ' | 2,426,000 | ' | 1,256,000 | |
Warrant [Member] | ' | ' | ' | ' | ' | ' | |
Note 4 - Investments (Details) [Line Items] | ' | ' | ' | ' | ' | ' | |
Available-for-sale Securities, Current | ' | ' | ' | ' | ' | 350,000 | |
Warrant [Member] | ' | ' | ' | ' | ' | ' | |
Note 4 - Investments (Details) [Line Items] | ' | ' | ' | ' | ' | ' | |
Marketable Securities, Realized Gain (Loss) | ' | ' | ' | $379,000 | ' | ' | |
[1] | The condensed consolidated balance sheet as of December 31, 2013 has been prepared using information from the audited consolidated balance sheet as of that date. |
Note_4_Investments_Details_Ava
Note 4 - Investments (Details) - Available-for-Sale Marketable Securities (USD $) | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2014 | Dec. 31, 2013 | ||
Note 4 - Investments (Details) - Available-for-Sale Marketable Securities [Line Items] | ' | ' | |
Fair value | $2,426,000 | $1,606,000 | [1] |
Marketable Securities [Member] | ' | ' | |
Note 4 - Investments (Details) - Available-for-Sale Marketable Securities [Line Items] | ' | ' | |
Cost basis | 328,000 | 255,000 | |
Unrealized gains included in accumulated other comprehensive income | 1,718,000 | 1,001,000 | |
Realized gains previously recognized as warrants | 380,000 | ' | |
Fair value | $2,426,000 | $1,256,000 | |
[1] | The condensed consolidated balance sheet as of December 31, 2013 has been prepared using information from the audited consolidated balance sheet as of that date. |
Note_6_Inventories_Details_Inv
Note 6 - Inventories (Details) - Inventories (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | |
Inventories [Abstract] | ' | ' | |
Raw materials | $5,546,000 | $5,876,000 | |
Work in process | 3,811,000 | 2,178,000 | |
Finished goods | 4,314,000 | 6,086,000 | |
$13,671,000 | $14,140,000 | [1] | |
[1] | The condensed consolidated balance sheet as of December 31, 2013 has been prepared using information from the audited consolidated balance sheet as of that date. |
Note_7_Equity_Investments_in_U1
Note 7 - Equity Investments in Unconsolidated Affiliate (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2005 | |
Note 7 - Equity Investments in Unconsolidated Affiliate (Details) [Line Items] | ' | ' | ' | ' | ' |
Equity Method Investment, Aggregate Cost | ' | ' | ' | ' | $1,450,000 |
Expense To Acquire Inventory | 5,019,000 | 4,140,000 | 13,486,000 | 9,132,000 | ' |
Income (Loss) from Equity Method Investments | 22,000 | 101,000 | 216,000 | 172,000 | ' |
Equity Method Investments | 2,924,000 | ' | 2,924,000 | ' | ' |
Cumulative Equity In Income of Unconsolidated Affiliate | 2,494,000 | ' | 2,494,000 | ' | ' |
Proceeds from Equity Method Investment, Dividends or Distributions | 77,000 | ' | ' | ' | ' |
Long Term Advance For Materials [Member] | Alpha ProTech Engineered Products [Member] | ' | ' | ' | ' | ' |
Note 7 - Equity Investments in Unconsolidated Affiliate (Details) [Line Items] | ' | ' | ' | ' | ' |
Equity Method Investment, Aggregate Cost | ' | ' | ' | ' | 942,000 |
Alpha ProTech Engineered Products [Member] | ' | ' | ' | ' | ' |
Note 7 - Equity Investments in Unconsolidated Affiliate (Details) [Line Items] | ' | ' | ' | ' | ' |
Equity Method Investment, Ownership Percentage | ' | ' | ' | ' | 41.66% |
Equity Method Investment, Aggregate Cost | ' | ' | ' | ' | 508,000 |
Maple Industries And Associates [Member] | ' | ' | ' | ' | ' |
Note 7 - Equity Investments in Unconsolidated Affiliate (Details) [Line Items] | ' | ' | ' | ' | ' |
Equity Method Investment, Ownership Percentage | ' | ' | ' | ' | 58.34% |
Equity Method Investment, Aggregate Cost | ' | ' | ' | ' | $708,000 |
Note_8_Accrued_Liabilities_Det
Note 8 - Accrued Liabilities (Details) - Accrued Liabilities (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | |
Accrued Liabilities [Abstract] | ' | ' | |
Payroll expenses | $248,000 | $178,000 | |
Bonuses payable | 473,000 | 664,000 | |
Uncertain tax position | 194,000 | 194,000 | |
$915,000 | $1,036,000 | [1] | |
[1] | The condensed consolidated balance sheet as of December 31, 2013 has been prepared using information from the audited consolidated balance sheet as of that date. |
Note_9_Basic_and_Diluted_Earni2
Note 9 - Basic and Diluted Earnings Per Common Share (Details) - Earnings Per Share Reconciliation (USD $) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |
Earnings Per Share Reconciliation [Abstract] | ' | ' | ' | ' |
Net income (numerator) (in Dollars) | $966,000 | $905,000 | $2,130,000 | $1,395,000 |
Shares (denominator): | ' | ' | ' | ' |
Basic weighted average common shares outstanding | 18,107,073 | 19,008,660 | 18,429,985 | 19,326,491 |
Add: Dilutive effect of common stock options | 280,349 | 996 | 259,289 | ' |
Diluted weighted average common shares outstanding | 18,387,422 | 19,009,656 | 18,689,274 | 19,326,491 |
Earnings per common share: | ' | ' | ' | ' |
Basic (in Dollars per share) | $0.05 | $0.05 | $0.12 | $0.07 |
Diluted (in Dollars per share) | $0.05 | $0.05 | $0.11 | $0.07 |
Note_10_Activity_of_Business_S2
Note 10 - Activity of Business Segments (Details) | 9 Months Ended |
Sep. 30, 2014 | |
Segment Reporting [Abstract] | ' |
Number of Operating Segments | 3 |
Note_10_Activity_of_Business_S3
Note 10 - Activity of Business Segments (Details) - Consolidated Net Sales (USD $) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Consolidated net sales | $13,213,000 | $12,692,000 | $35,421,000 | $33,298,000 |
Operating Segments [Member] | Building Supply [Member] | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Consolidated net sales | 8,546,000 | 8,238,000 | 21,482,000 | 20,460,000 |
Operating Segments [Member] | Disposable Protective Apparel [Member] | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Consolidated net sales | 3,456,000 | 3,336,000 | 10,612,000 | 9,610,000 |
Operating Segments [Member] | Infection Control [Member] | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Consolidated net sales | $1,211,000 | $1,118,000 | $3,327,000 | $3,228,000 |
Note_10_Activity_of_Business_S4
Note 10 - Activity of Business Segments (Details) - Reconciliation of Total Segment Income to Total Consolidated Net Income (USD $) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |
Segment Reporting, Revenue Reconciling Item [Line Items] | ' | ' | ' | ' |
Consolidated net income | $966,000 | $905,000 | $2,130,000 | $1,395,000 |
Provision for income taxes | 460,000 | 408,000 | 993,000 | 660,000 |
Common Stock [Member] | ' | ' | ' | ' |
Segment Reporting, Revenue Reconciling Item [Line Items] | ' | ' | ' | ' |
Gain on marketable securities | ' | ' | 409,000 | ' |
Operating Segments [Member] | Building Supply [Member] | ' | ' | ' | ' |
Segment Reporting, Revenue Reconciling Item [Line Items] | ' | ' | ' | ' |
Consolidated net income | 1,749,000 | 1,668,000 | 3,893,000 | 3,668,000 |
Operating Segments [Member] | Disposable Protective Apparel [Member] | ' | ' | ' | ' |
Segment Reporting, Revenue Reconciling Item [Line Items] | ' | ' | ' | ' |
Consolidated net income | 395,000 | 389,000 | 1,161,000 | 950,000 |
Operating Segments [Member] | Infection Control [Member] | ' | ' | ' | ' |
Segment Reporting, Revenue Reconciling Item [Line Items] | ' | ' | ' | ' |
Consolidated net income | 392,000 | 403,000 | 1,047,000 | 1,052,000 |
Operating Segments [Member] | ' | ' | ' | ' |
Segment Reporting, Revenue Reconciling Item [Line Items] | ' | ' | ' | ' |
Consolidated net income | 2,536,000 | 2,460,000 | 6,101,000 | 5,670,000 |
Corporate, Non-Segment [Member] | ' | ' | ' | ' |
Segment Reporting, Revenue Reconciling Item [Line Items] | ' | ' | ' | ' |
Consolidated net income | $1,110,000 | $1,147,000 | $3,387,000 | $3,615,000 |
Note_10_Activity_of_Business_S5
Note 10 - Activity of Business Segments (Details) - Consolidated Net Property and Equipment, Goodwill and Intangible Assets (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
Segment Reporting, Asset Reconciling Item [Line Items] | ' | ' |
Consolidated assets | $3,545,000 | $3,215,000 |
Operating Segments [Member] | Building Supply [Member] | ' | ' |
Segment Reporting, Asset Reconciling Item [Line Items] | ' | ' |
Consolidated assets | 2,668,000 | 2,144,000 |
Operating Segments [Member] | Disposable Protective Apparel [Member] | ' | ' |
Segment Reporting, Asset Reconciling Item [Line Items] | ' | ' |
Consolidated assets | 449,000 | 483,000 |
Operating Segments [Member] | Infection Control [Member] | ' | ' |
Segment Reporting, Asset Reconciling Item [Line Items] | ' | ' |
Consolidated assets | 420,000 | 568,000 |
Operating Segments [Member] | ' | ' |
Segment Reporting, Asset Reconciling Item [Line Items] | ' | ' |
Consolidated assets | 3,537,000 | 3,195,000 |
Corporate, Non-Segment [Member] | ' | ' |
Segment Reporting, Asset Reconciling Item [Line Items] | ' | ' |
Consolidated assets | $8,000 | $20,000 |